Increase of interferon-beta for anti-virus therapy for respiratory diseases
摘要
<p>The present invention provides an agent selected from (a) an agent that increases endogeneous interferon beta (IFN-²) expression in the lung; or (b) a polynucleotide which is capable of expressing such an agent for use in the treatment of rhinovirus-induced exacerbation of a respiratory disease selected from asthma and chronic obstructive pulmonary disease (COPD), wherein said treatment is by airway delivery of said agent.</p>
申请公布号
EP2206512(A2)
申请公布日期
2010.07.14
申请号
EP20100161661
申请日期
2005.03.07
申请人
UNIVERSITY OF SOUTHAMPTON
发明人
DAVIES, DONNA, ELIZABETH;WARK, PETER, ALEXANDER, BLANCH;HOLGATE, STEPHEN;JOHNSTON, SEBASTIAN, L